dihydroergocryptine has been researched along with erythromycin in 2 studies
Studies (dihydroergocryptine) | Trials (dihydroergocryptine) | Recent Studies (post-2010) (dihydroergocryptine) | Studies (erythromycin) | Trials (erythromycin) | Recent Studies (post-2010) (erythromycin) |
---|---|---|---|---|---|
5 | 0 | 2 | 14,524 | 1,138 | 1,926 |
Protein | Taxonomy | dihydroergocryptine (IC50) | erythromycin (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 1.156 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 1.045 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 1.156 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.039 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 1.156 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K | 1 |
Furuya, K; Lan, LB; Sanglard, D; Schuetz, EG; Schuetz, JD; Yasuda, K | 1 |
2 other study(ies) available for dihydroergocryptine and erythromycin
Article | Year |
---|---|
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine | 2002 |
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydroergocryptine; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Mice; Mice, Knockout; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins; Reserpine; Swine; Tissue Distribution; Transfection; Vinblastine | 2002 |